Last Updated: Apr 21, 2016
- Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations
D? Andrea E, et al. Genetics in Medicine (2016) April 14 - Identification of Novel BRCA Founder Mutations in Middle Eastern Breast Cancer Patients Using Capture and Sanger Sequencing Analysis.
Bu Rong, et al. International journal of cancer 2016 4 - Frequency and Significance of Abnormal Pancreatic Imaging in Patients with BRCA1 and BRCA2 Genetic Mutations.
Chahla Elie, et al. Scientifica 2016 0 5619358 - Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy.
Matulonis Ursula A, et al. Cancer 2016 4 - Mutation detection rates associated with specific selection criteria for BRCA1/2 testing in 1854 high-risk families: A monocentric Italian study.
Azzollini Jacopo, et al. European journal of internal medicine 2016 4 - Decreased Expression of BRCA2 Accelerates Sporadic Breast Cancer Progression.
Saha Soumi, et al. Indian journal of surgical oncology 2015 12 (4) 378-83 - Impact of Clinical Genetics Attendance at a Gynecologic Oncology Tumor Board on Referrals for Genetic Counseling and BRCA Mutation Testing.
Cohen Paul A et al. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2016 Apr - BRCA1 Gene Mutations and Influence of Chemotherapy on Autophagy and Apoptotic Mechanisms in Egyptian Breast Cancer Patients.
Abdel-Mohsen Mohamed Ahmed, et al. Asian Pacific journal of cancer prevention : APJCP 2016 0 (3) 1285-92 - Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation.
Boudin L, et al. Bone marrow transplantation 2016 4 - Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer families.
Riahi Aouatef et al. Breast cancer (Tokyo, Japan) 2016 Mar - UK BRCA mutation testing in patients with ovarian cancer.
George Angela et al. British journal of cancer 2015 Dec 113 Suppl 1S17-21 - BRCA testing, treatment patterns and survival in platinum-sensitive recurrent ovarian cancer - an observational cohort study.
Unni Sudhir K et al. Journal of ovarian research 2016 9(1) 18 - Molecular insights into the OGG1 gene, a cancer risk modifier in BRCA1 and BRCA2 mutations carriers.
Benitez-Buelga Carlos, et al. Oncotarget 2016 3 - Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer.
Kummar Shivaani, et al. Investigational new drugs 2016 3 - Beyond BRCA: Lynch Syndrome
My gene counsel, March 22, 2016 - Non-Neoplastic Conditions of the Ovaries in Grossly Normal Adnexa: A Clinicopathologic Study of 403 Completely Embedded Cases.
Seidman Jeffrey D, et al. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2016 3 - Bad Luck Or Bad Genes? Dealing With BRCA And 'A Cancer In The Family',
NPR, March 14, 2016 - Eligibility Criteria and Genetic Testing Results from a High-Risk Cohort for Hereditary Breast and Ovarian Cancer Syndrome in Southeastern Ontario.
Vidal Ricardo Dos Santos et al. The Journal of molecular diagnostics : JMD 2016 Feb - FORCE family letter for BRCA1 and BRCA2 carriers
Disease: Breast Cancer|Ovarian Cancer; Type: Tools; State: Multiple States - Breast cancer in high-risk Afrikaner families: Is BRCA founder mutation testing sufficient?
Seymour Heather Jessica et al. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2016 106(3) 264-7 - A cost analysis of a cancer genetic service model in the UK.
Slade Ingrid et al. Journal of community genetics 2016 Feb - Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis.
Phi Xuan-Anh, et al. British journal of cancer 2016 2 - Adding In Silico Assessment of Potential Splice Aberration to the Integrated Evaluation of BRCA Gene Unclassified Variants.
Vallée Maxime P, et al. Human mutation 2016 2 - Prioritizing Variants in Complete Hereditary Breast and Ovarian Cancer (HBOC) Genes in Patients Lacking known BRCA Mutations.
Caminsky Natasha G, et al. Human mutation 2016 2 - Low prevalence of HER2 positivity amongst BRCA1 and BRCA2 mutation carriers and in primary BRCA screens.
Evans D G, et al. Breast cancer research and treatment 2016 2 (3) 597-601 - Talking about BRCA in your family tree
Disease: Breast Cancer|Ovarian Cancer; Type: Tools; State: Multiple States - FORCE Letter to Relatives about Genetic Mutation
Disease: Breast Cancer|Ovarian Cancer; Type: Tools; State: Multiple States - Cancerous leptomeningitis and familial congenital hypopituitarism.
Vujovic S, et al. Endocrine 2016 2 - BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.
Rosenberg Shoshana M et al. JAMA oncology 2016 Feb - More young breast cancer patients having genetic tests,
by Kathryn Doyle, Reuters, February 18, 2016
- Human (455)
- Pathogen (0)
- Human (121)
- Pathogen (0)
No hay comentarios:
Publicar un comentario